Myriad Genetics Inc (MYGN)

Cash & Equivalents

$115.20M

Quarterly · Period ending: · USD

MYGN logo

MYGN Cash & Equivalents

Latest reported$115.20M
MYGN Quarterly Cash & Equivalents ($28.60M → $115.20M)
High-resolution chart · PNG

MYGN cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
35,936,817
96,201,023
92,427,846
58,631,551
56,214,736
28,780,000
27,700,000
15,700,000
5,400,000
8,300,000
17,300,000
9,200,000
14,600,000
13,400,000
17,000,000
20,400,000
15,700,000
16,700,000
15,300,000
14,800,000
13,200,000
26,300,000
28,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.